The Kroger's Board of Directors today declared a quarterly dividend of 35 cents per share to be paid on December 1, 2025, to shareholders of record as of the close of business on November 14, 2025. The company's quarterly dividend has grown at a 13% compounded annual growth rat - 2025-09-19 13:00:37
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Fidelity Low Volatility Factor ETF (Symbol: FDLO) where we have detected an approximate $122.5 million dollar outflow -- that's a 8.7% decrease week - 2025-08-27 12:03:36
Representative Lisa C. McClain (R-Michigan) recently bought shares of Abbott Laboratories (NYSE:ABT). In a filing disclosed on August 13th, the Representative disclosed that they had bought between $1,001 and $15,000 in Abbott Laboratories stock on June 24th. The trade occurred in the Representative’s “CHARLES SCHWAB BROKERAGE ACCOUNT 924” account. Representative Lisa C. McClain also recently […] - 2025-08-19 03:04:49
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR Portfolio S&P 500 ETF (Symbol: SPLG) where we have detected an approximate $389.9 million dollar inflow -- that's a 0.5% increase week over - 2025-08-18 11:52:49
Representative Josh Gottheimer (D-New Jersey) recently sold shares of Abbott Laboratories (NYSE:ABT). In a filing disclosed on August 11th, the Representative disclosed that they had sold between $1,001 and $15,000 in Abbott Laboratories stock on July 18th. The trade occurred in the Representative’s “MORGAN STANLEY – SELECT UMA ACCOUNT # 1” account. Representative Josh Gottheimer […] - 2025-08-13 03:04:43
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Vanguard Total Stock Market ETF (Symbol: VTI) where we have detected an approximate $4.2 billion dollar inflow -- that's a 0.8% increase week over we - 2025-08-07 11:52:01
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Russell 1000 ETF (Symbol: IWB) where we have detected an approximate $314.1 million dollar inflow -- that's a 0.7% increase week over week in - 2025-07-30 11:52:59
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the JPMorgan US Quality Factor ETF (Symbol: JQUA) where we have detected an approximate $177.8 million dollar inflow -- that's a 2.8% increase week over - 2025-07-22 12:18:30
Abbott Laboratories (NYSE:ABT – Free Report) had its price objective lowered by Wells Fargo & Company from $147.00 to $142.00 in a research report report published on Friday,Benzinga reports. The firm currently has an overweight rating on the healthcare product maker’s stock. ABT has been the subject of a number of other research reports. Mizuho […] - 2025-07-21 05:42:50
Abbott Laboratories (NYSE:ABT – Free Report) had its target price cut by Raymond James Financial from $142.00 to $141.00 in a research report report published on Friday morning,Benzinga reports. They currently have an outperform rating on the healthcare product maker’s stock. ABT has been the subject of a number of other reports. Wells Fargo & […] - 2025-07-21 05:02:49
Abbott Laboratories (NYSE:ABT – Free Report) had its target price lowered by BTIG Research from $148.00 to $145.00 in a report issued on Friday morning,Benzinga reports. The firm currently has a buy rating on the healthcare product maker’s stock. Several other research firms also recently weighed in on ABT. Piper Sandler restated an “overweight” rating […] - 2025-07-21 04:18:48
Among the underlying components of the S&P 500 index, we saw noteworthy options trading volume today in Abbott Laboratories (Symbol: ABT), where a total of 30,443 contracts have traded so far, representing approximately 3.0 million underlying shares. That amounts to about 4 - 2025-07-17 14:32:50
(RTTNews) - While reporting financial results for the second quarter on Wednesday, Abbott Laboratories (ABT) provided adjusted earnings guidance for the third quarter and raised its adjusted earnings outlook for the full-year 2025. - 2025-07-17 08:50:15
(RTTNews) - Abbott Laboratories (ABT) announced a profit for its second quarter that Increased from last year and beat the Street estimates. - 2025-07-17 08:37:46
Abbott Laboratories (NYSE:ABT) is set to release its second-quarter earnings on Thursday, July 17, 2025. For event-driven traders, analyzing the stock’s historical reactions to earnings reports can provide valuable insights. - 2025-07-16 02:32:25
Abbott Laboratories (NYSE:ABT – Free Report) had its price objective lifted by Evercore ISI from $140.00 to $145.00 in a report issued on Tuesday morning,Benzinga reports. The firm currently has an outperform rating on the healthcare product maker’s stock. A number of other analysts have also recently weighed in on ABT. Leerink Partnrs upgraded Abbott […] - 2025-07-11 02:42:50
Rossby Financial LCC acquired a new stake in Abbott Laboratories (NYSE:ABT – Free Report) during the first quarter, HoldingsChannel.com reports. The fund acquired 275 shares of the healthcare product maker’s stock, valued at approximately $35,000. Other large investors also recently modified their holdings of the company. Redwood Park Advisors LLC purchased a new stake in […] - 2025-07-06 05:31:01
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Russell 1000 ETF (Symbol: IWB) where we have detected an approximate $665.0 million dollar outflow -- that's a 1.6% decrease week over week - 2025-07-03 11:52:20
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the The Health Care Select Sector SPDR Fund (Symbol: XLV) where we have detected an approximate $218.1 million dollar outflow -- that's a 0.6% decrease - 2025-06-24 11:50:08
Abbott Laboratories (NYSE:ABT – Get Free Report) was upgraded by investment analysts at Leerink Partnrs to a “hold” rating in a note issued to investors on Monday,Zacks.com reports. Leerink Partnrs also issued estimates for Abbott Laboratories’ Q2 2025 earnings at $1.26 EPS, Q3 2025 earnings at $1.30 EPS, Q4 2025 earnings at $1.48 EPS, Q1 […] - 2025-06-18 03:14:43
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the The Health Care Select Sector SPDR Fund (Symbol: XLV) where we have detected an approximate $258.6 million dollar outflow -- that's a 0.7% decrease - 2025-06-16 11:48:07
The NASDAQ 100 After Hours Indicator is down -23.38 to 21,423.67. The total After hours volume is currently 90,667,353 shares traded.The following are the most active stocks for the after hours session: Intel Corporation (INTC) is -0.03 at $21.38, with 6,758,456 shares traded. I - 2025-05-19 17:05:09
(RTTNews) - Abbott Laboratories (ABT) Thursday announced positive data from REFLECT studies of its FreeStyle Libre continuous glucose monitoring (CGM) technology. - 2025-05-15 10:53:09
Today's Research Daily features new research reports on 16 major stocks, including NVIDIA Corp. (NVDA), Abbott Laboratories (ABT) and Linde plc (LIN), as well as a micro-cap stock Tredegar Corp. (TG). - 2025-05-08 17:17:00
Today's Research Daily features new research reports on 16 major stocks, including The Coca-Cola Co. (KO), Abbott Laboratories (ABT) and RTX Corp. (RTX), as well as two micro-cap stocks Investors Title Co. (ITIC) and Armanino Foods of Distinction, Inc. (AMNF). - 2025-04-23 18:37:00
Abbott Laboratories (NYSE:ABT – Get Free Report) shot up 4.9% during trading on Wednesday following a better than expected earnings announcement. The company traded as high as $133.26 and last traded at $132.36. 2,236,510 shares were traded during trading, a decline of 68% from the average session volume of 7,046,563 shares. The stock had previously […] - 2025-04-18 02:10:45
All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.